8-K - Xilio Therapeutics, Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Xilio Therapeutics, Inc. filed a Certificate of Amendment to its Restated Certificate of Incorporation on March 12, 2026, constituting an amendment to its articles of incorporation and a material modification to the rights of security holders. Exhibit 3.1 contains the Certificate of Amendment.

Key Takeaways

1Filed Certificate of Amendment on 2026-03-12

2Amends Restated Certificate of Incorporation

3Reported under Item 5.03

4Material modification to security holder rights under Item 3.03

5Exhibit 3.1: Certificate of Amendment

Current Report Details

Event Type

Securities Modification

Charter Amendment

Exhibits

Disclosure

Mandatory

Variant

8-K

Items Reported

3.03

. Material Modification to Rights of Security Holders. To the extent required by Item 3.03 of Form 8-K, the information contained in Item 5.03 of this Current R

Securities Modification

5.03

. Amendment to Articles of Incorporation or Bylaws; Change in Fiscal Year. On March 12, 2026, Xilio Therapeutics, Inc. (the “Company”) filed a Certificate of Am

Charter Amendment

9.01

. Financial Statements and Exhibits. (d) Exhibits. Exhibit Number Description 3.1 Certificate of Amendment to Restated Certificate of Incorporation, as amended,

Exhibits Only

Source Document

Exhibits (3)

3.1

EX-3.1

8-K

99.1

EX-99.1